Water → 1-Butyl-3-[1-(Cyclohexylmethyl)piperidin-4-yl]-4-phenyl-3,4-dihydro-2(1H)-quinazolinone

Temperature

60 °C

To a solution of 100 mg (0.25 mmol) of 3-[1-(cyclohexylmethyl)piperidin-4-yl]-4-phenyl-3,4-dihydro-2(1H)-quinazolinone in 2 ml of DMF, 22 mg (0.55 mmol) of sodium hydride (60%) were added at room temperature and stirred at about 60° C. for one hour. After allowing the reaction mixture to stand cool, a solution of 69 mg (0.38 mmol) of 1-iodobutane in 1 ml of DMF was added thereto at room temperature and stirred at about 60° C. for 2 hours. The reaction mixture was poured into water, extracted with ethyl acetate, washed with water and saturated brine, and dried over anhydrous magnesium sulfate. After the solvent was evaporated under reduced pressure, the obtained residue was purified by silica gel column chromatography (chloroform—10% methanol/chloroform) to give 88 mg (0.19 mmol) of the title compound as colorless oil.

1. temperatureto stand cool
2. stirringat room temperature and stirred at about 60° C. for 2 hours
3. extractionextracted with ethyl acetate
4. washwashed with water and saturated brine
5. dry with materialdried over anhydrous magnesium sulfate
6. customAfter the solvent was evaporated under reduced pressure
7. customthe obtained residue was purified by silica gel column chromatography (chloroform—10% methanol/chloroform)

ORD record

ord-4d34a768494f4be89f0062a6d828672e

Source dataset

uspto-grants-2003_11

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US06645971B1